# A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine

> clinical trial · VERIFIED · 2026-07-14

Status: NOT_YET_RECRUITING · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) · Condition: COVID -19

- Company: National Institute of Allergy and Infectious Diseases (NIAID)
- Sector: COVID -19
- Primary source: https://clinicaltrials.gov/study/NCT07703475

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.